InsiderClue
Insiders · Profile

Smither John W

Director at NewAmsterdam Pharma Co N.V · Director at GENELUX · Chief Financial Officer at Arcutis Biotherapeutics. Filing since 29 Sep 2020. CIK 0001559583

NAMS NewAmsterdam Pharma Co N.V. Director · 1 trade GNLX GENELUX Corp Director · 3 trades ARQT Arcutis Biotherapeutics, Inc. Chief Financial Officer · 13 trades
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS NewAmsterdam Pharma Co N.V.
4 Sep 2026
Director
Sold at will
1,600
$40.51K
15.4%
GNLX GENELUX Corp
1 Jul 2026
Director
Sold at will
12,000
$34.90K
11.6%
GNLX GENELUX Corp
29 May 2024
Director
Bought
6,250
no price
90.3%
GNLX GENELUX Corp
13 Sep 2023
Director
Sold at will
900
$18.70K
11.5%
ARQT Arcutis Biotherapeutics, Inc.
10 Mar 2021
Chief Financial Officer
Sold, plan not stated
1,250
$41.13K
1.4%
ARQT Arcutis Biotherapeutics, Inc.
10 Mar 2021
Chief Financial Officer
Sold, plan not stated
500
$16.45K
1.1%
ARQT Arcutis Biotherapeutics, Inc.
1 Mar 2021
Chief Financial Officer
Sold, plan not stated
773
$26.44K
3.1%
ARQT Arcutis Biotherapeutics, Inc.
10 Feb 2021
Chief Financial Officer
Sold, plan not stated
2,000
$71.28K
2.2%
ARQT Arcutis Biotherapeutics, Inc.
10 Feb 2021
Chief Financial Officer
Sold, plan not stated
750
$26.73K
2.9%
ARQT Arcutis Biotherapeutics, Inc.
1 Feb 2021
Chief Financial Officer
Sold, plan not stated
3,750
$131.25K
4.0%
ARQT Arcutis Biotherapeutics, Inc.
1 Feb 2021
Chief Financial Officer
Sold, plan not stated
1,250
$43.75K
4.7%
ARQT Arcutis Biotherapeutics, Inc.
19 Jan 2021
Chief Financial Officer
Sold, plan not stated
1,250
$37.50K
1.3%
ARQT Arcutis Biotherapeutics, Inc.
19 Jan 2021
Chief Financial Officer
Sold, plan not stated
500
$15.00K
1.9%
ARQT Arcutis Biotherapeutics, Inc.
14 Dec 2020
Chief Financial Officer
Sold, plan not stated
3,750
$112.50K
3.8%
ARQT Arcutis Biotherapeutics, Inc.
14 Dec 2020
Chief Financial Officer
Sold, plan not stated
1,500
$45.00K
5.6%
ARQT Arcutis Biotherapeutics, Inc.
29 Sep 2020
Chief Financial Officer
Sold, plan not stated
1,250
$37.50K
1.3%
ARQT Arcutis Biotherapeutics, Inc.
29 Sep 2020
Chief Financial Officer
Sold, plan not stated
500
$15.00K
2.1%
17 decisions on file.